Clinical characterization of necrotizing enterocolitis in neonates with or without congenital heart disease: a case-control study.

Kaiyishaer Balati, Zhuoming Xu, Limin Zhu, Xiaolei Gong
Author Information
  1. Kaiyishaer Balati: Department of Neonatology, Second People's Hospital of Kashi Prefecture, Kashi, 844099, Xinjiang Province, China.
  2. Zhuoming Xu: Cardiac intensive care unit, Department of Cardiothoracic Surgery, Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  3. Limin Zhu: Cardiac intensive care unit, Department of Cardiothoracic Surgery, Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  4. Xiaolei Gong: Cardiac intensive care unit, Department of Cardiothoracic Surgery, Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. espresso_1985@126.com.

Abstract

BACKGROUND: This study aimed to analyze the clinical characteristics and differences between neonates with congenital heart disease (CHD)-related neonatal necrotizing enterocolitis (NEC) and those with non-CHD-related neonatal NEC.
METHOD: This retrospective study included patients with CHD who met Bell's staging diagnostic criteria and were hospitalized between 2014 and 2023 in the Cardiac Intensive Care Unit of Cardiothoracic Surgery, Shanghai Children's Medical Center affiliated to Shanghai Jiao Tong University School of Medicine. These patients comprised the CHD-related NEC group (CHD-NEC group). Meanwhile, the control group included randomly matched non-CHD-related NEC children (nCHD-NEC group) admitted to the neonatal department of the Second People's Hospital in Kashi Prefecture according to the 1:2 matching principle. patients' basic information, adverse clinical events before NEC onset as well as NEC severity and treatment were recorded.
RESULTS: The CHD-NEC group comprised 60 cases, whereas the nCHD-NEC group comprised 120 cases. Compared with the nCHD-NEC group, the CHD-NEC group had an older gestational age (38.71 [37.89, 39.67] weeks vs. 30.65 [29.68, 32.29] weeks, p���<���0.001); a heavier birth weight (3.2 [2.69, 3.67] kg vs. 1.39 [1.1, 1.59] kg, p���<���0.001); and higher proportions of patent ductus arteriosus (73.3% vs. 26.7%, p���<���0.001), shock (81.7% vs. 36.7%, p���<���0.001), and mechanical ventilation requirement (91.7% vs. 51.7%, p���<���0.001). At disease onset, the CHD-NEC group had a higher vasoactive drug score (16.75 [7.26, 23.63] vs. 0 [0, 10], p���<���0.001) but lower values for the proportion of infants who were small for gestational age (15% vs. 33.3%, p���=���0.045), incidence of premature rupture of membranes (3.3% vs. 26.7%, p���=���0.002), incidence of early onset sepsis (6.7% vs. 23.3%, p���=���0.038), and incidence of late onset sepsis (46.7% vs. 70%, p���=���0.036) than the nCHD-NEC group. Among children who required abdominal surgery, the CHD-NEC group tended to have more colon involvement (6.6% vs. 0.8%, p���=���0.063), but no significant difference in mortality was noted between the two groups.
CONCLUSION: Children with CHD-NEC and nCHD-NEC have significantly different clinical characteristics. CHD-NEC is mainly observed in full-term infants with appropriate weight for gestational age, and perioperative intestinal ischemia may be the main pathophysiology. Conversely, nCHD-NEC is mainly noted in preterm infants, possibly related to immature intestinal development and infection. Large prospective clinical research is warranted to explore the pathogenesis, pathophysiology, indicator monitoring, and treatment plan for children with NEC.

Keywords

References

  1. J Perinatol. 2015 Nov;35(11):949-53 [PMID: 26248130]
  2. J Neonatal Perinatal Med. 2019;12(1):9-12 [PMID: 30347623]
  3. World J Pediatr Congenit Heart Surg. 2017 Jan;8(1):62-68 [PMID: 28033074]
  4. Clin Perinatol. 2023 Sep;50(3):669-681 [PMID: 37536771]
  5. Newborn (Clarksville). 2022 Jan-Mar;1(1):170-176 [PMID: 36864827]
  6. Pediatrics. 2000 Nov;106(5):1080-7 [PMID: 11061778]
  7. J Cardiothorac Vasc Anesth. 2021 Oct;35(10):3067-3077 [PMID: 33069558]
  8. Ital J Pediatr. 2021 Nov 14;47(1):226 [PMID: 34775993]
  9. Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420963818 [PMID: 33016797]
  10. Pediatrics. 2007 Feb;119(2):330-5 [PMID: 17272623]
  11. Lancet. 2016 Feb 13;387(10019):649-660 [PMID: 26628328]
  12. N Engl J Med. 2011 Jan 20;364(3):255-64 [PMID: 21247316]
  13. J Clin Med. 2022 Jul 09;11(14): [PMID: 35887751]
  14. J Perinatol. 2013 Oct;33(10):783-5 [PMID: 23636100]
  15. Am J Perinatol. 2015 Jun;32(7):633-8 [PMID: 25486286]
  16. J Am Coll Surg. 2015 Jun;220(6):1018-1026.e14 [PMID: 25868405]
  17. Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):590-600 [PMID: 27534694]
  18. Int J Mol Sci. 2023 Jan 27;24(3): [PMID: 36768793]
  19. Front Pediatr. 2021 Dec 20;9:802607 [PMID: 34988043]
  20. Ital J Pediatr. 2022 Feb 3;48(1):19 [PMID: 35115028]
  21. Ital J Pediatr. 2022 May 4;48(1):65 [PMID: 35509048]
  22. Semin Perinatol. 2008 Apr;32(2):70-82 [PMID: 18346530]
  23. J Pediatr Surg. 2017 Oct 12;: [PMID: 29111080]
  24. BMC Pediatr. 2020 Dec 7;20(1):553 [PMID: 33287760]
  25. Ital J Pediatr. 2022 Dec 29;48(1):206 [PMID: 36581928]
  26. J Pediatr. 2019 Dec;215:11-16.e2 [PMID: 31561958]
  27. J Matern Fetal Neonatal Med. 2020 Feb;33(3):398-403 [PMID: 29945481]
  28. Transl Pediatr. 2019 Jul;8(3):212-226 [PMID: 31413955]
  29. Adv Neonatal Care. 2021 Oct 01;21(5):349-355 [PMID: 33958518]
  30. Clin Perinatol. 2020 Jun;47(2):399-412 [PMID: 32439119]
  31. Ital J Pediatr. 2022 Sep 8;48(1):170 [PMID: 36076277]
  32. Pediatr Surg Int. 2019 Oct;35(10):1143-1162 [PMID: 31420743]
  33. Pediatr Cardiol. 2021 Dec;42(8):1688-1699 [PMID: 34510235]
  34. J Pediatr. 2020 May;220:86-92.e3 [PMID: 31982088]
  35. Sci Rep. 2022 Dec 10;12(1):21407 [PMID: 36496465]
  36. Ann Surg. 1978 Jan;187(1):1-7 [PMID: 413500]
  37. J Pediatr Surg. 2019 Sep;54(9):1755-1760 [PMID: 30635129]
  38. Clin Nutr. 2018 Dec;37(6 Pt B):2303-2305 [PMID: 30471662]
  39. Pediatr Cardiol. 2018 Apr;39(4):774-785 [PMID: 29392349]
  40. Hosp Pediatr. 2019 Dec;9(12):998-1006 [PMID: 31744846]
  41. J Pediatr Surg. 2018 May;53(5):914-917 [PMID: 29526349]
  42. Front Pediatr. 2021 Jan 06;8:593926 [PMID: 33490000]

Grants

  1. 20220101/SJTU Trans-med Awards Research

MeSH Term

Humans
Enterocolitis, Necrotizing
Infant, Newborn
Male
Female
Retrospective Studies
Heart Defects, Congenital
Case-Control Studies
China

Word Cloud

Created with Highcharts 10.0.0groupvs7%NECCHD-NECnCHD-NECp���<���0001p���=���0clinicalonset3%studyheartdiseaseneonatalenterocolitiscomprisedchildrengestationalage3126infantsincidencecharacteristicsneonatescongenitalCHDnecrotizingnon-CHD-relatedincludedpatientsShanghaitreatmentcases3967]weeksweightkghigher230sepsis6notedmainlyintestinalpathophysiologyBACKGROUND:aimedanalyzedifferences-relatedMETHOD:retrospectivemetBell'sstagingdiagnosticcriteriahospitalized20142023CardiacIntensiveCareUnitCardiothoracicSurgeryChildren'sMedicalCenteraffiliatedJiaoTongUniversitySchoolMedicineCHD-relatedMeanwhilecontrolrandomlymatchedadmitteddepartmentSecondPeople'sHospitalKashiPrefectureaccording1:2matchingprinciplePatients'basicinformationadverseeventswellseverityrecordedRESULTS:60whereas120Comparedolder3871[37893065[29683229]heavierbirth2[269[159]proportionspatentductusarteriosus73shock8136mechanicalventilationrequirement9151vasoactivedrugscore1675[763][010]lowervaluesproportionsmall15%33045prematurerupturemembranes002early038late4670%036Amongrequiredabdominalsurgerytendedcoloninvolvement6%8%063significantdifferencemortalitytwogroupsCONCLUSION:Childrensignificantlydifferentobservedfull-termappropriateperioperativeischemiamaymainConverselypretermpossiblyrelatedimmaturedevelopmentinfectionLargeprospectiveresearchwarrantedexplorepathogenesisindicatormonitoringplanClinicalcharacterizationwithoutdisease:case-controlCongenitalNecrotizingNeonatesPreterminfant

Similar Articles

Cited By

No available data.